Cardiopulmonary Stress Testing Systems Market size is anticipated to surpass USD 45 billion by the end of 2036, growing at a CAGR of 5% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of cardiopulmonary stress testing systems was over USD 6 billion. The growth of the market may be further stimulated by rising research and development studies that demonstrate the effectiveness of cardiopulmonary stress tests in detecting cardiac conditions. For example, a study published in May 2022 by the National Institute of Health suggested that selected parameters of the cardiopulmonary exercise test were related to the severity of angina symptoms and quality of life.
The severity of myocardial ischemia is detected by the oxygen pulse plateau. Thus, the benefit of early diagnosis of heart diseases with stress tests may aid in lowering the mortality rate associated with these diseases, as a result fuelling the market expansion.
Due to the increasing incidence of cardiac problems, the market for cardiopulmonary stress testing systems is expected to increase. To reduce hospital stays and decrease mortality, it is necessary to detect CVDs before they occur. To identify and assess the severity of cardiovascular disease, physicians advise using a cardiopulmonary stress test.
The market for cardiopulmonary stress testing systems is expanding as more and more people are using the test equipment to assess their cardiac function. To determine their ability to adapt to the hemodynamic demands of exercise, adult patients with CHD undergo cardiopulmonary exercise tests.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024 - 2036 |
CAGR |
5% |
Base Year Market Size (2023) |
USD 6 Billion |
Forecast Year Market Size (2036) |
USD 45 Billion |
Regional Scope |
|
Product (Cardiopulmonary Exercise Testing, Stress ECG, Pulse Oximeter, Single-Photon Emission Computed Tomography, Stress Blood Pressure Monitors)
Based on the product, the cardiopulmonary exercise testing segment in the cardiopulmonary stress testing systems market is set to hold a share of 60% by the end of 2036. The global uptake of the exercise test system is expected to be driven by its positive results in early diagnosis of diseases, which will lead to market growth. For example, a study by the National Institute of Health, published in June 2022, stated that exercise testing systems are useful for training prescriptions and for defining responses to clinical trials.
A unique opportunity to expand the application of these tests and facilitate their interpretation is provided by recent advances in wearable technology and artificial intelligence. This segment is projected to grow strongly in the coming years, driven by advances in wireless technology. Because of their accuracy and the shortest operating time, exercise testing systems account for a significant part of the market. The growing adoption of these systems is also contributing to the increase in physician and patient preference due to their cost-effectiveness and multiple applications, which are likely to fuel market growth.
The most widely used cardiac screening test is exercise cardiac stress testing. The patient will be exercising on the treadmill according to a standard protocol, gradually increasing its speed and increase in altitude. The ECG, heart rate, rhythm, and blood pressure of the patient shall be monitored at all times while exercising cardiac stress tests.
End-Users (Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Center, Diagnostic Centers)
In terms of end-users, the hospital segment is set to hold 40% share of the global cardiopulmonary stress testing systems market by the end of 2036. The hospital is preferable because of government measures to increase hospital admissions for cardiovascular disease, as well as an aging population with a combination of risk factors.
In view of the growing preference for hospital-based treatments for the early detection of cardiovascular diseases and increased stress tests carried out in these establishments, hospitals are gaining momentum. To provide the best quality of medical care and reduce complications in existing patients, hospitals have increased their efforts.
Our in-depth analysis of the global market includes the following segments:
Product |
|
End-Users |
|
North American Market Forecasts
The cardiopulmonary stress testing systems market in the North American region is set to hold the largest revenue share of 36% by the end of 2036. The growth can be attributed to the prevalence of cardiovascular and pulmonary disorders such as arrhythmia, heart failures, ischemic heart disease, dyspnea, and heart valve imbalance in the United States, generating higher demand for CPST systems. For example, the prevalence of obesity was 39.7% in 2021, which is very high, according to an update from the CDC published in May 2022.
Cardiopulmonary diseases are also caused by obesity as a result, driving the market's growth. The region’s high share of total revenue is due to the rise in lifestyle diseases, as well as increased awareness amongst medical professionals on the benefits of CCPT and access to modern healthcare infrastructure across the region.
European Market Statistics
The cardiopulmonary stress testing systems market in the Europe region is set to grow significantly during the time period 2024-2036. The growth of the German market in the region is driven by increasing demand for cardiovascular disease monitoring and diagnostic devices.
In addition, an increase in elderly patients, and increasing awareness of stress tests boost the market growth of cardiopulmonary stress testing systems. Moreover, market revenue in Germany is driven by the high adoption and penetration of advanced testing systems in public health centers and institutions that assist nurses and doctors in real-time monitoring of patients' health.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?